1. Home
  2. BDSX vs SACH Comparison

BDSX vs SACH Comparison

Compare BDSX & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.95

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.18

Market Cap

52.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
SACH
Founded
2005
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
53.0M
52.0M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
BDSX
SACH
Price
$7.95
$1.18
Analyst Decision
Strong Buy
Hold
Analyst Count
5
3
Target Price
$32.50
$2.00
AVG Volume (30 Days)
63.1K
232.7K
Earning Date
11-03-2025
11-05-2025
Dividend Yield
N/A
16.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,173,000.00
$3,906,000.00
Revenue This Year
$20.75
N/A
Revenue Next Year
$25.05
$1.73
P/E Ratio
N/A
N/A
Revenue Growth
22.29
N/A
52 Week Low
$3.44
$0.80
52 Week High
$32.20
$1.40

Technical Indicators

Market Signals
Indicator
BDSX
SACH
Relative Strength Index (RSI) 52.12 60.16
Support Level $7.77 $1.00
Resistance Level $8.38 $1.16
Average True Range (ATR) 0.57 0.05
MACD -0.01 0.02
Stochastic Oscillator 60.38 69.57

Price Performance

Historical Comparison
BDSX
SACH

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: